World's Best Scientists 2026 revealed!
Thomas C. Pearson

Thomas C. Pearson

D-Index & Metrics

Immunology

D-Index
82
Citations
23310
World Ranking
1510
National Ranking
760

Thomas C. Pearson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas C. Pearson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 280 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas C. Pearson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas C. Pearson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas C. Pearson is affiliated with Emory University in the United States. Their research focuses primarily on the field of Medicine, with a concentration on transplantation, infectious diseases, epidemiology, virology, and accounting.

The main topics covered in their work include:

  • Renal Transplantation Outcomes and Treatments
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS drug development and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV-related health complications and treatments

Their recent publications are as follows:

  • "CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept," 2020, American Journal of Transplantation
  • "National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States," 2021, Clinical Infectious Diseases
  • "Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States," 2021, Clinical Transplantation
  • "Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression," 2023, Transplantation Direct
  • "Tax-compliant transfer pricing of intra-group services: The soft drink case," 2022, Journal of Accounting Education

Thomas C. Pearson collaborates frequently with several co-authors, including:

  • Sander Florman
  • Peter G. Stock
  • Valentina Stosor
  • Christine M. Durand
  • Shikha Mehta

Their work has appeared in various publication venues, with a majority in transplantation-related journals:

  • American Journal of Transplantation
  • Clinical Infectious Diseases
  • Clinical Transplantation
  • Transplantation Direct
  • Journal of Accounting Education

Best Publications

  • Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

    Christian P. Larsen;Eric T. Elwood;Diane Z. Alexander;Shannon C. Ritchie

  • 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.

    Walter W. Shuford;Kerry Klussman;Douglas D. Tritchler;Deryk T. Loo

  • Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

    Christian P. Larsen;Thomas C. Pearson;Andrew B. Adams;Paul Tso

  • Heterologous immunity provides a potent barrier to transplantation tolerance.

    Andrew B. Adams;Matthew A. Williams;Thomas R. Jones;Nozomu Shirasugi

  • Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways.

    Kenneth Cardona;Gregory S Korbutt;Zvonimir Milas;James Lyon

  • Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.

    C P Larsen;S C Ritchie;R Hendrix;P S Linsley

  • Transplantation tolerance induced by CTLA4-Ig.

    Thomas C. Pearson;Diane Z. Alexander;Kevin J. Winn;Peter S. Linsley

  • CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway

    Christian P. Larsen;Diane Z. Alexander;Diane Hollenbaugh;Eric T. Elwood

  • Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations

    C P Larsen;S C Ritchie;T C Pearson;P S Linsley

  • Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade–resistant allograft rejection

    Joel Trambley;Adam W. Bingaman;Angello Lin;Eric T. Elwood

  • Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning

    Megan M. Durham;Adam W. Bingaman;Andrew B. Adams;Jongwon Ha

  • IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.

    Bogumila T. Konieczny;Zhenhua Dai;Eric T. Elwood;Sohail Saleem

  • 4-1BB Ligand, a Member of the TNF Family, Is Important for the Generation of Antiviral CD8 T Cell Responses

    Joyce T. Tan;Jason K. Whitmire;Rafi Ahmed;Thomas C. Pearson

  • Heterologous immunity: an overlooked barrier to tolerance.

    Andrew B. Adams;Thomas C. Pearson;Christian P. Larsen

  • Transplanting the highly sensitized patient : The emory algorithm

    R. A. Bray;J. D. L. Nolen;C. Larsen;T. Pearson

  • Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival

    Andrew B. Adams;Nozomu Shirasugi;Thomas R. Jones;Megan M. Durham

  • The CD40 pathway in allograft rejection, acceptance, and tolerance

    Christian P Larsen;Thomas C Pearson

  • Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory

    M. Suresh;Jason K. Whitmire;Laurie E. Harrington;Christian P. Larsen

  • Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.

    Andrew B. Adams;Megan M. Durham;Leslie Kean;Nozomu Shirasugi

  • Anti-CD40 therapy extends renal allograft survival in rhesus macaques.

    Thomas C. Pearson;Joel Trambley;Kris Odom;Daniel C. Anderson

  • Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection

    Vaiva Vezys;David Masopust;Christopher C. Kemball;Daniel L. Barber

Frequent Co-Authors

Christian P. Larsen
Christian P. Larsen Emory University
Allan D. Kirk
Allan D. Kirk Duke University
Rafi Ahmed
Rafi Ahmed Emory University
Peter S. Linsley
Peter S. Linsley Benaroya Research Institute
Mandy L. Ford
Mandy L. Ford Emory University
Diane Hollenbaugh
Diane Hollenbaugh Bonum Therapeutics
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Howard M. Gebel
Howard M. Gebel Emory University
Jason K. Whitmire
Jason K. Whitmire University of North Carolina at Chapel Hill
Fadi G. Lakkis
Fadi G. Lakkis University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and research. Many choose to begin with foundational nursing programs, which provide essential clinical knowledge and patient care skills. If you are looking for flexible options, consider programs like the easiest accelerated nursing programs to get into. These programs offer a fast track into nursing careers while accommodating busy schedules.

Entry-level nursing can also be pursued through easy LPN programs to get into, which serve as a stepping stone to more advanced roles. From there, advancing to specialized roles such as nurse practitioners is a common pathway, supported by accessible options like the easiest NP programs to get into.

For those focusing on mental health within immunological contexts or chronic diseases, online psychiatric mental health nurse practitioner programs offer targeted training. Programs with strong clinical components, such as the best online psychiatric mental health nurse practitioner programs, ensure graduates are well-prepared for clinical practice.

Choosing the right related degree can significantly impact career pathways in Immunology, blending lab research with patient-centered roles in healthcare.

Best Scientists Citing Thomas C. Pearson

Trending Scientists

Recently Published Articles